Condition
Larynx Squamous Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Larynx Squamous Cell Carcinoma clinical trials that are recruiting, at sites in 3 countries (most in Germany (1), United States (1), Canada (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 3Countries
Newest Larynx Squamous Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Proactive risk-based coordination to shorten time from surgery to post-operative radiation for head and neck cancer | — | Montreal, Quebec | Recruiting | Sep 18, 2025 |
| Sacituzumab govitecan plus cetuximab for recurrent or metastatic head and neck squamous cell cancer | Phase 2 | Basking Ridge, New Jersey and 6 other locations | Recruiting | Jul 14, 2025 |
| Immune biomarker testing in cisplatin-ineligible head and neck squamous cell cancer patients treated with chemoradiation and docetaxel | — | Erlangen, Bavaria | Recruiting | Apr 27, 2025 |
All recruiting trials (3)
-
Proactive risk-based coordination to shorten time from surgery to post-operative radiation for head and neck cancer
This pilot tests whether an automated care-coordination system (PRONTO-HN) can help adults with oral or laryngeal squamous cell carcinoma begin post-operative radiotherapy within 42 days after surgery.
-
Sacituzumab govitecan plus cetuximab for recurrent or metastatic head and neck squamous cell cancer
This trial will test whether combining sacituzumab govitecan with cetuximab works and is safe for people whose head and neck squamous cell cancer has returned or spread after prior immunotherapy.
-
Immune biomarker testing in cisplatin-ineligible head and neck squamous cell cancer patients treated with chemoradiation and docetaxel
This project will test whether immune markers from tumor tissue, blood, saliva and stool can help predict outcomes and show increased tumor immune activity in people with oropharynx, hypopharynx, larynx or oral cavity squamous cell cancer who can't take cisplatin and are receiving chemoradiation with docetaxel.
Related topics
Quick answers
How many Larynx Squamous Cell Carcinoma clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Germany (1 trial), United States (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.